Cargando…
The Use of Human Serum Samples to Study Malignant Transformation: A Pilot Study
Obesity and excess adiposity account for approximately 20% of all cancer cases; however, biomarkers of risk remain to be elucidated. While fibroblast growth factor-2 (FGF2) is emerging as an attractive candidate biomarker for visceral adipose tissue mass, the role of circulating FGF2 in malignant tr...
Autores principales: | Holowatyj, Andreana N., Gigic, Biljana, Warby, Christy A., Ose, Jennifer, Lin, Tengda, Schrotz-King, Petra, Ulrich, Cornelia M., Bernard, Jamie J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534413/ https://www.ncbi.nlm.nih.gov/pubmed/34685650 http://dx.doi.org/10.3390/cells10102670 |
Ejemplares similares
-
Impact of Pre-Blood Collection Factors on Plasma Metabolomic Profiles
por: Hardikar, Sheetal, et al.
Publicado: (2020) -
Multiplatform Urinary Metabolomics Profiling to Discriminate Cachectic from Non-Cachectic Colorectal Cancer Patients: Pilot Results from the ColoCare Study
por: Ose, Jennifer, et al.
Publicado: (2019) -
Targeted Plasma Metabolic Profiles and Risk of Recurrence in Stage II and III Colorectal Cancer Patients: Results from an International Cohort Consortium
por: Ose, Jennifer, et al.
Publicado: (2021) -
Higher Plasma Creatinine Is Associated with an Increased Risk of Death in Patients with Non-Metastatic Rectal but Not Colon Cancer: Results from an International Cohort Consortium
por: Ose, Jennifer, et al.
Publicado: (2023) -
Repeat physical activity measurement by accelerometry among colorectal cancer patients—feasibility and minimal number of days of monitoring
por: Skender, Stephanie, et al.
Publicado: (2015)